Phreesia, Inc. (NYSE:PHR) Shares Sold by Brown Advisory Inc.

Brown Advisory Inc. lowered its stake in Phreesia, Inc. (NYSE:PHR - Free Report) by 32.6% in the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 3,770,480 shares of the company's stock after selling 1,824,110 shares during the quarter. Brown Advisory Inc. owned approximately 6.42% of Phreesia worth $96,373,000 as of its most recent filing with the Securities & Exchange Commission.

Several other large investors have also added to or reduced their stakes in PHR. Envestnet Asset Management Inc. grew its position in shares of Phreesia by 11.1% in the 1st quarter. Envestnet Asset Management Inc. now owns 23,183 shares of the company's stock worth $593,000 after buying an additional 2,325 shares during the last quarter. Bank of New York Mellon Corp grew its holdings in Phreesia by 1.0% during the first quarter. Bank of New York Mellon Corp now owns 197,315 shares of the company's stock valued at $5,043,000 after purchasing an additional 2,048 shares during the period. Calamos Advisors LLC bought a new position in shares of Phreesia in the first quarter worth about $1,596,000. Principal Financial Group Inc. bought a new position in shares of Phreesia in the first quarter worth about $1,623,000. Finally, Teacher Retirement System of Texas bought a new position in Phreesia during the first quarter valued at approximately $206,000. Institutional investors own 92.10% of the company's stock.

Phreesia Stock Performance

Shares of PHR stock traded down $1.93 during midday trading on Friday, hitting $26.74. 504,545 shares of the company were exchanged, compared to its average volume of 455,631. The firm has a market capitalization of $1.59 billion, a P/E ratio of -36.13 and a beta of 0.72. The company has a debt-to-equity ratio of 0.02, a quick ratio of 1.95 and a current ratio of 1.95. The firm's 50 day moving average price is $26.34 and its two-hundred day moving average price is $26.37. Phreesia, Inc. has a 52 week low of $17.07 and a 52 week high of $30.53.

Phreesia (NYSE:PHR - Get Free Report) last posted its earnings results on Wednesday, May 28th. The company reported ($0.07) earnings per share for the quarter, topping analysts' consensus estimates of ($0.13) by $0.06. Phreesia had a negative net margin of 9.83% and a negative return on equity of 16.23%. The firm had revenue of $115.94 million for the quarter, compared to analyst estimates of $115.00 million. During the same period in the previous year, the firm posted ($0.05) EPS. The company's revenue for the quarter was up 14.5% compared to the same quarter last year. As a group, equities research analysts anticipate that Phreesia, Inc. will post -1.1 earnings per share for the current year.

Insider Activity

In other Phreesia news, SVP David Linetsky sold 23,729 shares of the business's stock in a transaction dated Friday, June 27th. The stock was sold at an average price of $28.50, for a total value of $676,276.50. Following the completion of the transaction, the senior vice president owned 193,510 shares of the company's stock, valued at approximately $5,515,035. The trade was a 10.92% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Michael Weintraub sold 7,431 shares of the business's stock in a transaction that occurred on Monday, June 9th. The shares were sold at an average price of $27.51, for a total value of $204,426.81. Following the transaction, the director owned 143,039 shares of the company's stock, valued at approximately $3,935,002.89. This trade represents a 4.94% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 54,781 shares of company stock valued at $1,504,911. 5.50% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

A number of equities research analysts have weighed in on the company. Citigroup reaffirmed a "buy" rating on shares of Phreesia in a research report on Wednesday, May 28th. DA Davidson cut their price target on Phreesia from $36.00 to $34.00 and set a "buy" rating for the company in a research note on Monday, April 14th. KeyCorp reduced their target price on Phreesia from $30.00 to $28.00 and set an "overweight" rating for the company in a report on Wednesday, April 16th. Truist Financial increased their price objective on Phreesia from $34.00 to $35.00 and gave the stock a "buy" rating in a research report on Thursday, May 29th. Finally, Wall Street Zen upgraded Phreesia from a "hold" rating to a "buy" rating in a research note on Sunday, June 1st. Twelve analysts have rated the stock with a buy rating, According to MarketBeat.com, the stock currently has an average rating of "Buy" and a consensus target price of $31.64.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.